SCHEMBL25140697

SCHEMBL25140697

CCCN(CC)c1ccc2c(COC(C)=O)cc(=S)oc2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IGLV6-57 P01721 3/20 0.49
▸ MAPT P10636 9/20 0.46
▸ KDM4E B2RXH2 8/20 0.46
▸ MEN1 O00255 7/20 0.46
▸ KMT2A Q03164 7/20 0.46
▸ GLA P06280 6/20 0.46
▸ HPGD P15428 6/20 0.46
▸ LMNA P02545 4/20 0.46
▸ CYP3A4 P08684 4/20 0.46
▸ CYP1A2 P05177 4/20 0.46
▸ CYP2C19 P33261 4/20 0.46
▸ SMN1; SMN2 Q16637 4/20 0.46
▸ POLB P06746 2/20 0.46
▸ ALDH1A1 P00352 10/20 0.43
▸ ATM Q13315 6/20 0.43
▸ L3MBTL1 Q9Y468 4/20 0.43
▸ HSD17B10 Q99714 4/20 0.43
▸ CASP1 P29466 3/20 0.43
▸ CASP7 P55210 3/20 0.43
▸ HTT P42858 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21771607 0.93 MAPT (0.52) IGLV6-57MAPTKDM4EMEN1KMT2A
SCHEMBL23915973 0.83 MAPT (0.51) IGLV6-57MAPTKDM4EMEN1KMT2A
SCHEMBL12894158 0.81 MAPT (0.67) IGLV6-57MAPTKDM4EMEN1KMT2A
SCHEMBL30430934 0.75 ALDH1A1 (0.53) IGLV6-57MAPTKDM4EMEN1KMT2A
SCHEMBL18972975 0.73 IGLV6-57 (0.60) IGLV6-57MAPTKDM4EMEN1KMT2A
SCHEMBL24860258 0.72 ALDH1A1 (0.49) IGLV6-57MAPTKDM4EMEN1KMT2A
SCHEMBL29255957 0.70 KDM4E (0.66) IGLV6-57MAPTKDM4EMEN1KMT2A
SCHEMBL13609755 0.70 KDM4E (0.62) IGLV6-57MAPTKDM4EMEN1KMT2A
SCHEMBL24235203 0.70 ALDH1A1 (0.47) IGLV6-57MAPTKDM4EMEN1KMT2A
SCHEMBL23663768 0.69 KDM4E (0.58) IGLV6-57MAPTKDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230124487-A1 A CONTROLLED DRUG RELEASE SYSTEM OF PHOTORESPONSIVE NANOCARRIERS, METHODS OF MAKING AND USING THEREOF THE UNIVERSITY OF HONG KONG (CN) 2023-04-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230124487-A1 A CONTROLLED DRUG RELEASE SYSTEM OF PHOTORESPONSIVE NANOCARRIERS, METHODS OF MAKING AND USING THEREOF GHRHR, ABCB1, GRPR IGLV6-57 2597/4885MAPT 1133/4885KDM4E 4413/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback